Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133490) titled 'Precise Treatment and Clinical Translation for Bladder Cancer' on Sept. 28.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Hunan Provincial People's Hospital

Condition: Bladder cancer

Intervention: Gold Standard:Histopathological diagnosis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-10

Target Sample Size: Target condition:500;Difficult condition:0

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=343637

Published by HT Digital Content Services with permission from Health Dai...